Phenylethylbarbituric Acid en es it fr

Phenylethylbarbituric Acid Brand names, Phenylethylbarbituric Acid Analogs

Phenylethylbarbituric Acid Brand Names Mixture

  • No information avaliable

Phenylethylbarbituric Acid Chemical_Formula

C12H12N2O3

Phenylethylbarbituric Acid RX_link

No information avaliable

Phenylethylbarbituric Acid fda sheet

Phenylethylbarbituric Acid msds (material safety sheet)

Phenylethylbarbituric_Acid MSDS

Phenylethylbarbituric Acid Synthesis Reference

Hoerlein, U.S. Pat. 1,025,872 (1912)

Phenylethylbarbituric Acid Molecular Weight

232.235 g/mol

Phenylethylbarbituric Acid Melting Point

174 oC

Phenylethylbarbituric Acid H2O Solubility

<0.01 g/100 mL

Phenylethylbarbituric Acid State

Solid

Phenylethylbarbituric Acid LogP

1.777

Phenylethylbarbituric Acid Dosage Forms

Tablet; Elixir

Phenylethylbarbituric Acid Indication

For the treatment of Epilepsy

Phenylethylbarbituric Acid Pharmacology

Phenobarbital, the longest-acting barbiturate, is used for its anticonvulsant and sedative-hypnotic properties in the management of all seizure disorders except absence (petit mal).

Phenylethylbarbituric Acid Absorption

Absorbed in varying degrees following oral, rectal or parenteral administration. The salts are more rapidly absorbed than are the acids. The rate of absorption is increased if the sodium salt is ingested as a dilute solution or taken on an empty stomach

Phenylethylbarbituric Acid side effects and Toxicity

CNS and respiratory depression which may progress to Cheyne-Stokes respiration, areflexia, constriction of the pupils to a slight degree (though in severe poisoning they may wshow paralytic dilation), oliguria, tachycardia, hypotension, lowered body temperature, and coma. Typical shock syndrome (apnea, circulatory collapse, respiratory arrest, and death) may occur.

Phenylethylbarbituric Acid Patient Information

PATIENT INFORMATION

Practitioners should give the following information and instructions to patients receiving barbiturates:

1. The use of phenobarbital carries with it an associated risk of psychological and/or physical dependence.
The patient should be warned against increasing the dose of the drug without consulting a physician.

2. Phenobarbital may impair mental and/or physical abilities required for the performance of potentially
hazardous tasks (e.g., driving, operating machinery, etc.).

3. Alcohol should not be consumed while taking phenobarbital. Concurrent use of phenobarbital with other
CNS depressants (e.g., alcohol, narcotics, tranquilizers, and antihistamines) may result in additional CNS
depressant

Phenylethylbarbituric Acid Organisms Affected

Humans and other mammals